Cholesterol Management in Toledo, Ohio: The First Oral PCSK9 Inhibitor Is Here
For patients in Toledo, Maumee, Perrysburg, Sylvania, and across Northwest Ohio who struggle to reach their LDL cholesterol (low-density lipoprotein, the so-called "bad" cholesterol) goals despite statins, diet, and exercise, a meaningful new option has arrived. The FDA has approved enlicitide (Lipfendra), the first oral PCSK9 inhibitor (a medication that blocks a protein in the liver called PCSK9, allowing the body to remove more LDL from the bloodstream). At Toledo Cardiolo
